KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) EBT Margin (2016 - 2025)

Historic EBT Margin for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 41.09%.

  • Eli Lilly's EBT Margin rose 272100.0% to 41.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 37.87%, marking a year-over-year increase of 130300.0%. This contributed to the annual value of 28.15% for FY2024, which is 89400.0% up from last year.
  • Latest data reveals that Eli Lilly reported EBT Margin of 41.09% as of Q3 2025, which was up 272100.0% from 43.56% recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's EBT Margin ranged from a high of 43.56% in Q2 2025 and a low of 4.5% during Q3 2023
  • For the 5-year period, Eli Lilly's EBT Margin averaged around 25.39%, with its median value being 25.13% (2023).
  • Per our database at Business Quant, Eli Lilly's EBT Margin crashed by -180500bps in 2023 and then soared by 272100bps in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's EBT Margin stood at 23.0% in 2021, then increased by 25bps to 28.71% in 2022, then fell by -7bps to 26.82% in 2023, then surged by 39bps to 37.23% in 2024, then increased by 10bps to 41.09% in 2025.
  • Its last three reported values are 41.09% in Q3 2025, 43.56% for Q2 2025, and 27.15% during Q1 2025.